In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
Laura Davisson, MD, MPH, FACP, professor of medicine, West Virginia University, discusses the rapidly evolving pharmacologic landscape for obesity management, including practical strategies for handling...
Bruce Y. Lee, MD, MBA, and Marie C. Ferguson, MSPH, answer our questions about their study on the impact of following different solid food feeding guidelines on weight trajectories of infants.
Carol Chelimo, PhD, and Cameron Grand, MbChB, PhD, answered our questions about their study examining the association between early exposure to antibiotics and subsequent body mass index and the likelihood...
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
Is obesity a causal risk factor for aortic stenosis? Researcher, Børge G. Nordestgaard, MD, DMSc, sheds light by answering our questions about his team’s latest study.
Considering pharmacotherapy for your patient with obesity? Here’s what you should know, according to Harold Bays, MD, who presented “Current and Future of Obesity Drug Therapies: Echoes of Today’s Metabolic...
Nearly half of patients with obesity also have depression, according to the CDC. In this Q&A, Leslie Heinberg, PhD, from Cleveland Clinic, discusses the association between depression and obesity, and...
